碘治疗工作场所空气中n 131I的监测结果与分析n

来源 :中华放射医学与防护杂志 | 被引量 : 0次 | 上传用户:zxw2yanzi
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的:了解碘治疗工作场所空气中n 131I气溶胶的活度浓度,估算核医学科医务人员吸入n 131I所致内照射剂量。n 方法:使用CF-1001BRL型便携式大容量空气采样器,采用碘盒收集山东省6家医院核医学科碘治疗工作场所空气中的n 131I气溶胶,利用HPGe-γ能谱仪对样品进行测量,得到6家医院碘治疗工作场所中n 131I的活度浓度值,并估算医务人员的内照射剂量。n 结果:6家医院碘治疗工作场所空气中n 131I的活度浓度范围为3.64~2.94×10n 3Bq/mn 3,控制区(病房、患者通道、分装间、远程操作给药室)n 131I的浓度水平明显高于监督区,监督区n 131I的浓度最高的是医护通道,为2.62×10n 2Bq/mn 3。核医学科医务人员两种职业待积有效剂量估算值为0.07~5.68 mSv,均未超过国家规定限值。n 结论:医院核医学科碘治疗工作场所仍存在不可忽视的n 131I气溶胶污染现象,应面向全国各地区核医学科开展内照射监测,探索更加合理的防护标准和方法。n “,”Objective:To understand the activity concentration of n 131I aerosol in the air of the iodine treatment workplace and estimate the internal dose of n 131I inhaled by medical staff in nuclear medicine.n Methods:Using CF-1001BRL portable large capacity air sampler, the n 131I aerosol in the iodine treatment workplace of nuclear medicine department of 6 hospitals in Shandong province was collected by iodine box, and the HPGe-γ energy spectrometer was used to measure the samples. Then 131I activity concentration in iodine treatment workplace at 6 hospitals was obtained, and the internal dose to medical staff was estimated.n Results:The n 131I activity concentration in the air in iodine treatment workplaces at 6 hospitals ranged from 3.64 to 2.94×10n 3 Bq/mn 3. The n 131I activity concentration in the controlled area (ward, patient passageway, subpacking room, operation administration room) was significantly higher than that in the supervised area. The highest n 131I activity concentration, 2.62×10n 2 Bq/mn 3, in the supervised area was found in the medical care passageway. The estimated effective dose to nuclear medicine workers was 0.07-5.68 mSv, not exceeding the national limit.n Conclusions:The phenomenon of n 131I aerosol contamination still exists in the iodine treatment workplaces of nuclear medicine departments in hospitals, so it is necessary to carry out internal radiation monitoring for nuclear medicine departments all around the country, and explore more reasonable protection standards and methods.n
其他文献
期刊
期刊
Background::Prospective analyses have yet to identify a consistent relationship between sleep duration and the incidence of gastrointestinal (GI) cancers. The effect of changes in sleep duration on GI cancer incidence has scarcely been studied. Therefore,
Background::The scale assessment was helpful in predicting the presence of antibodies to autoimmune encephalitis. This study aimed to evaluate the application of antibody prevalence in Chinese patients with epilepsy and encephalopathy (APE2-CHN) and respo
The emergence of non-alcoholic fatty liver disease (NAFLD) as the leading chronic liver disease worldwide raises some concerns. In particular, NAFLD is closely tied to sedentary lifestyle habits and associated with other metabolic diseases, such as obesit
Backgrounds::Azithromycin mass drug administration (MDA) is a key part of the strategy for controlling trachoma. This systematic review aimed to comprehensively summarize the present studies of azithromycin MDA on trachoma; provide an overview of the impa
Background::Despite the recommendation of inhaled corticosteroids (ICSs) plus long-acting beta 2-agonist (LABA) and leukotriene receptor antagonist (LTRA) or ICS/LTRA as stepwise approaches in asthmatic children, there is a lack of published systematic re
目的:研究n 131I治疗分化型甲状腺癌(DTC)患者体内放射性活度及外部剂量水平的变化规律,分析二者之间的关系,并估算400 MBq患者剂量当量率的修正因子。n 方法:研究对象为43例甲状腺全切术后,首次行n 131I“清甲”治疗的DTC患者,服药量为1 850~3 700 MBq,平均服药量(2 405±777)MBq。分别于口服n 131I后2、6、20、22、24、27、30、44、46、48、54、68及72 h,测定患者的体内剩余放射性活度以及患者前部0.
期刊
目的:探索接触n 131I放射性核素放射工作人员内照射剂量估算方法。n 方法:选择某n 131I放射性药物生产企业和某开展n 131I甲亢和甲状腺癌治疗的医院核医学科放射工作人员,使用便携式高纯锗(HPGe)γ谱仪,以7 d为周期,连续4次测量甲状腺部位n 131I活度,结合人员接触n 131I的轮岗方式,估算内照射剂量。n 结果:以监测月份为典型月份估算人员内照射剂量时,调查企业从事n 131I放射性药物分装的生产人员年待积有效